Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › R-CHOP

R-CHOP

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of R-CHOP

2 trials tracked of R-CHOP.

2Trials tracked
0Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 2 2
  1. Phase 2 A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin Completed
  2. Phase 2 Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma Completed

Showing the 2 most-cited and recently-updated of 2 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
R-CHOP immunochemotherapy associated with symptom resolution and complete metabolic response in a case of intravascular large B-cell lymphoma
Rheumatology Cohort
R-CHOP immunochemotherapy associated with symptom resolution and complete metabolic response in a case of intravascular large B-cell lymphoma High Fever and High Ferritin May Signal Rare Blood Cancer
This case report and literature review describes a 60-year-old woman with intravascular large B-cell lymphoma (IVLBCL), fever of unknown ori…
A rare case suggests a specific lab pattern might help doctors find a hidden blood cancer when standard tests fail.
Frontiers Apr 24, 2026
High FGR protein expression associated with worse relapse-free survival in de novo DLBCL patients treated with R-CHOP
Oncology Cohort
High FGR protein expression associated with worse relapse-free survival in de novo DLBCL patients treated with R-CHOP New Protein Test Predicts Lymphoma Relapse Risk
This retrospective cohort study evaluated 91 patients with de novo diffuse large B-cell lymphoma treated with R-CHOP.
A new protein test identifies diffuse large B-cell lymphoma patients at high risk of relapse before treatment fails, giving doctors a crucia…
Frontiers Apr 17, 2026